Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+T cells: A new model for latency

Archives of Virology

Volumn 145, Issue 11, 2000, Pages 2259-2272

  Minagawa, H ^a   Yanagi, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY PRODUCTION; B LYMPHOCYTE; CD4 ANTIGEN; CELL PROLIFERATION; CELL SURVIVAL; GENETIC STRAIN; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; MOUSE; SPLEEN CELL; T LYMPHOCYTE; VIRUS INFECTION; VIRUS TRANSMISSION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CORNEA; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNE SERA; MICE; MICE, INBRED BALB C; MICE, SCID; SPLEEN; VIRUS LATENCY;

EID: 0034522876     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050070019     Document Type: Article

References (43)

1. Modulation of murine herpes simplex virus type 1 retinitis in the uninoculated eye by CD4+T lymphocytes
2. B cell-deficient mice have increased susceptibility to HSV-1 encephalomyelitis and mortality
3. Herpes simplex virus vaccines
4. A severe combined immunodeficiency mutation in the mouse
5. The role of the innate immune system in the reconstituted SCID mouse model of herpetic stromal keratitis
6. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1
7. Resistance to herpetic stromal keratitis in immunized B-cell-deficient mice
8. Herpes simplex virus latency and the immune response
9. Herpetic stromal keratitis: An immunopathologic disease mediated by CD4+T lymphocytes
10. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains
11. Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes
12. Oral inoculation of SCID mice with an attenuated herpes simplex virus-1 strain causes persistent enteric nervous system infection and gastric ulcers without direct mucosal infection
13. Specific and nonspecific immune stimulation of MHC-II-deficient mice results in chronic HSV-1 infection of the trigeminal ganglia following ocular challenge
14. Either a CD4(+) or CD8(+) T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice
15. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice
16. IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice
17. Herpes simplex virus latency
18. Alphaherpesvirus latency: Its role in disease and survival of the virus in nature
19. Pathogenesis of herpes simplex virus in B cell-suppressed mice: The relative roles of cell-mediated and humoral immunity
20. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system
21. Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation
22. Necrotizing chorioretinitis in mice inoculated with herpes simplex virus type 1 with or without glycoprotein C: Anterior chamber-associated immune deviation does not persist
23. Genetic immunization against herpes simplex virus. Protection in mediated by CD4+T lymphocytes
24. Herpetic stromal keratitis in the reconstituted scid mouse model
25. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2
26. Necrotizing retinitis in severe combined immunodeficiency (SCID) mice following intracameral inoculation of herpes simplex virus type 1
27. Suppression of an infectious virus spread and corneal opacification by the combined use of recombinant interferon beta and interleukin-10 following corneal infection with herpes simplex virus-1 in mice
28. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID)
29. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1
30. Different roles for L3T4+ and Lyt2+T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system
31. Pathogenesis and immunology of herpesvirus infections of the nervous system
32. Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia
33. Acute and latent infection of sensory ganglia with herpes simplex virus: Immune control and virus reactivation
34. Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses
35. The role of T cell immunity in control of herpes simplex virus
36. Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: An in vivo study of virus antigen and cytokines
37. Role of antibody in primary and recurrent herpes simplex virus infection
38. Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus
39. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-γ (IFN-γ)
40. Herpes simplex virus type 1 mutant strain in 1814 establishes a unique, slowly progressive infection in SCID mice
41. A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement
42. Experimental investigation of herpes simplex virus latency
43. Herpes simplex viruses